technIQ Smart Procedural Automation is a set of automated robotic movements designed for the CorPath® GRX System. The automations replicate the manual techniques of highly skilled interventionalists to provide predictable and consistent movements that aid in advanced navigation, lesion crossing, and device manipulation during complex coronary and peripheral interventional procedures.
Rotate on Retract, the first automation in the technIQ series was introduced in 2018 to assist with wire navigation. The software has been expanded to include four new moves: Spin, Wiggle, Dotter and Constant Speed.*
To reduce navigation time in difficult anatomies, such as tortuous vessels, RoR automatically rotates the guidewire when joystick is retracted and redirects guidewire tip.
To prevent prolapses in tortuous anatomy during guidewire navigation, Wiggle oscillates the guidewire as it advances.
To efficiently cross lesions in complex cases and difficult anatomies, Spin utilizes clockwise and counterclockwise rotations of the guidewire.
GUIDEWIRE DRIVE
To aid in lesion crossing and delivery of therapy, especially in very narrow or calcified lesions, Dotter utilizes rapid linear back-and-forth motions as the device advances.
DEVICE DRIVE
BOTH
To enable precise measurement of the anatomy, Constant Speed maintains a controlled, consistent speed of 2mm/s or 5mm/s, as selected by the user on the guidewire or device.
Watch video
Watch video
Watch video
“ The addition of the technIQ automation series to the CorPath GRX system affords the operator a variety of automated wire movements to navigate diverse vascular anatomy. ”
“ With the help of created algorithms taken from the best interventional operators you can get rid of the trial & error method for vessel navigation. It is as if Tiger Woods hits a golf ball and we can make the robot hit the golf ball the same way. That way everyone gets the opportunity to play at that high level.”
“ This new software algorithm gives the operator new possibilities to advance and facilitate the treatment, especially with complex lesions.”
“ Adoption requires purposeful practice – that means that you have to change how you do things, but if you do change, you will become much more efficient, much safer for you and for your patients.”
* technIQ is pending 510(k) clearance, and is not yet commercially available in the United States.
1 Images courtesy of Clinique Pasteur, Toulouse, France
2 Madder R, et al. 2017. Disclaimers: Compared to robotic wiring without automation, preclinical study data may not be predictive of clinical results
Disclaimer: The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
